Cancer Biopsy Market - Top Companies and Manufacturers

Companies Dominating the Cancer Biopsy Landscape

Companies are adopting a wide range of strategies to remain competitive in the market. This includes development and innovations, majorly in tissue biopsies, liquid biopsies, and advanced molecular diagnostics. For instance, in September 2023, Mermaid Medical launched M∙Biopsy semi-automatic and fully automatic biopsy needles, for soft tissue biopsy solutions. Collaborations and partnerships with research institutions, diagnostic labs, and pharmaceutical companies are also common, allowing firms to expand their technological capabilities. Regulatory approvals are also explored strategically by these prominent players for obtaining certifications and meeting global standards. 

Some of the prominent players in the market include:

• ANGLE plc
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• BD (Becton, Dickinson and Company)
• Biodesix (Integrated Diagnostics)
• Chronix Biomedical, Inc (Oncocyte Corporation )
• Devicor Medical Products, Inc.
• GRAIL, Inc.
• Hologic, Inc.
• Illumina, Inc.
• IZI Medical Products 
• Lucence Health Inc.
• Myriad Genetics, Inc.
• Oncimmune Holdings PLC
• Personal Genome Diagnostics Inc.
• QIAGEN N.V.